supreme horse racing 『Pharmaceutical Headlines』Zhibei Medical completes new financing, Sanofi and Lexicon break up Many drugstores of this type have become popular, with annual sales of over 100 ...
The resubmitted NDA for sotagliflozin for adults with T1D and CKD included post hoc analyses from the TANDEM clinical development program and post hoc analysis from the SCORED trial.
As recently as last month, Lexicon Pharmaceuticals Inc. was holding out hope regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for glycemic control in adults with type 1 ...